RNS Number : 8853S
Legal & General UCITS ETF PLC
14 July 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
13/07/2020 |
IE00BFXR5Q31 |
11767267 |
USD |
140103302.85 |
11.906 |
| L&G UK Equity UCITS ETF |
13/07/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
10955404.62 |
9.130 |
| L&G Global Equity UCITS ETF |
13/07/2020 |
IE00BFXR5S54 |
2900000 |
USD |
33347847.30 |
11.499 |
| L&G Japan Equity UCITS ETF |
13/07/2020 |
IE00BFXR5T61 |
11185000 |
USD |
118543435.03 |
10.598 |
| L&G Europe ex UK Equity UCITS ETF |
13/07/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
103289999.36 |
11.034 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
13/07/2020 |
IE00BFXR5W90 |
5081427 |
USD |
53912569.21 |
10.610 |
| L&G Clean Water UCITS ETF |
13/07/2020 |
IE00BK5BC891 |
1500000 |
USD |
15531524.58 |
10.354 |
| L&G Artificial Intelligence UCITS ETF |
13/07/2020 |
IE00BK5BCD43 |
6796000 |
USD |
89276904.44 |
13.137 |
| L&G Healthcare Innovation UCITS ETF |
13/07/2020 |
IE00BK5BC677 |
3000000 |
USD |
38361290.48 |
12.787 |
| L&G Pharma Breakthrough UCITS ETF |
13/07/2020 |
IE00BF0H7608 |
2150000 |
USD |
26057991.35 |
12.120 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
13/07/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
95808759.97 |
10.414 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
13/07/2020 |
IE00BKLWY790 |
57800000 |
USD |
620097643.60 |
10.728 |
| L&G Battery Value-Chain UCITS ETF |
13/07/2020 |
IE00BF0M2Z96 |
12950000 |
USD |
130419493.07 |
10.071 |
| L&G Ecommerce Logistics UCITS ETF |
13/07/2020 |
IE00BF0M6N54 |
5950000 |
USD |
66150341.49 |
11.118 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
13/07/2020 |
IE00BMW3QX54 |
47430616 |
USD |
830367344.65 |
17.507 |
| L&G Cyber Security UCITS ETF |
13/07/2020 |
IE00BYPLS672 |
81911776 |
USD |
1559919329.42 |
19.044 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVGZGMNFFVGGZZ
